J. Weigl

Progranulin Gene Variability and Plasma Levels in Bipolar Disorder and Schizophrenia

N. Bresolin, A. Altamura, D. Galimberti, 2012, PloS one.

The cytokine IL‐17A as a marker of treatment resistance in major depressive disorder?

R. Rupprecht, S. Hilbert, T. Baghai, 2019, The European journal of neuroscience.

Association of Chemokine (C-C Motif) Receptor 5 and Ligand 5 with Recovery from Major Depressive Disorder and Related Neurocognitive Impairment

R. Rupprecht, S. Hilbert, T. Wetter, 2021, Neuroimmunomodulation.

Non-Fatal Intoxication with a High Dose of Citalopram in a Suicidal 14-Year-Old Girl.

M. Gerlach, T. Vloet, K. Egberts, 2019, Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie.

Classical Risk Factors and Inflammatory Biomarkers: One of the Missing Biological Links between Cardiovascular Disease and Major Depressive Disorder

B. Bondy, C. Born, P. Zill, 2018, International journal of molecular sciences.

Further evidence for plasma progranulin as a biomarker in bipolar disorder.

S. Kittel-Schneider, A. Reif, J. Volkert, 2014, Journal of affective disorders.

Differential effects of the translocator protein 18 kDa (TSPO) ligand etifoxine and the benzodiazepine alprazolam on startle response to predictable threat in a NPU-threat task after acute and short-term treatment

A. Mühlberger, R. Rupprecht, C. Nothdurfter, 2022, Psychopharmacology.

Dissociation of endocrine responses to the Trier Social Stress Test in Virtual Reality (VR-TSST) by the benzodiazepine alprazolam and the translocator protein 18 kDa (TSPO) ligand etifoxine

A. Mühlberger, R. Rupprecht, T. Wetter, 2020, Psychoneuroendocrinology.